The page is the record's research on the issuer — no analyst, no rating, no view. # Kailera Therapeutics, Inc. (NASDAQ: KLRA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Kailera Therapeutics, Inc., listed on NASDAQ under ticker KLRA, with ISIN US4829311020. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 64 filings in the twelve months to 2026-11-08, across 19 filing days. The median gap between filing days is 11.5 days. The latest filing is dated 2026-11-04 and is of type results, 4 days before the record date. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days, and a median latency of 5.0 days across 4359 issuers. The sector median is 63.0 filings, a median cadence gap of 6.0 days, and a median latency of 4.0 days across 526 issuers. Filings by type are: directors' dealings 42, regulatory filings 11, prospectus 4, results 6, corporate news 1. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2026-04-14 and 2026-04-15. It holds no delisting and no name change. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The field has no research houses on the record: none was found on the investor-relations pages read. The count is 0. ## Open research The record holds no openly published research notes: none was found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is sealed. The issuer's sealed years are 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002096997.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/KLRA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/KLRA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/KLRA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp